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During early stages of development, encephalic vesicles are composed by a
layer of neuroepithelial cells surrounding a central cavity filled with embryonic
cerebrospinal fluid (eCSF). This fluid contains several morphogens that regulate
proliferation and differentiation of neuroepithelial cells. One of these neurogenic
factors is SCO-spondin, a giant protein secreted to the eCSF from early stages
of development. Inhibition of this protein in vivo or in vitro drastically decreases
the neurodifferentiation process. Other important neurogenic factors of the eCSF
are low density lipoproteins (LDL), the depletion of which generates a 60%
decrease in mesencephalic explant neurodifferentiation. The presence of several
LDL receptor class A (LDLrA) domains (responsible for LDL binding in other
proteins) in the SCO-spondin sequence suggests a possible interaction between both
molecules. This possibility was analyzed using three different experimental approaches:
(1) Bioinformatics analyses of the SCO-spondin region, that contains eight LDLrA
domains in tandem, and of comparisons with the LDL receptor consensus sequence;
(2) Analysis of the physical interactions of both molecules through immunohistochemical
colocalization in embryonic chick brains and through the immunoprecipitation of
LDL with anti-SCO-spondin antibodies; and (3) Analysis of functional interactions
during the neurodifferentiation process when these molecules were added to a
culture medium of mesencephalic explants. The results revealed that LDL and SCO-
spondin interact to form a complex that diminishes the neurogenic capacities that
both molecules have separately. Our work suggests that the eCSF is an active
signaling center with a complex regulation system that allows for correct brain
development.
Keywords: embryonic cerebrospinal fluid, SCO-spondin, low density lipoproteins, chick embryo, neurogenesis,
brain development
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Introduction
In all vertebrates the central nervous system (CNS) originates
from the neural tube, a hollow structure delimited by
neuroepithelial cells and filled with embryonic cerebrospinal
fluid (eCSF). Correct brain development requires interaction
between the neuroepithelium and eCSF. Through this
interaction, the neuroepithelium survives, proliferates, and
differentiates in response to molecules present in the eCSF.
Some of these molecules originate in the serum, while others
are secreted by neuroepithelial cells (Gato et al., 2005; Gato and
Desmond, 2009).
Embryonic cerebrospinal fluid participates in CNS
development through two mechanisms. First, the accumulation
of eCSF in brain cavities generates an intraluminal pressure that
promotes the proliferation of neuroepithelial cells (Desmond
and Jacobson, 1977; Desmond et al., 2005, 2014). Second,
eCSF contains growth factors and morphogens that interact
with the neuroepithelium. Different studies in chick (Gallus
gallus) and rat (Rattus norvegicus) embryos found eCSF to
promote neural cell differentiation, proliferation, and survival
in neuroepithelium explants, although this was dependent on
the embryonic stage of the eCSF and of the explants analyzed
(Lehtinen et al., 2011; Yari et al., 2013; Gato et al., 2014). These
studies showed that the eCSF has molecules which provide an
essential environment for neuroepithelial cells, as compared to
serum and serum-free mediums. It is additionally implied that
some eCSF molecules are of non-plasmatic origin and would be
directly secreted by neuroepithelial cells (Gato et al., 2005; Salehi
and Mashayekhi, 2006; Gato and Desmond, 2009; Martin et al.,
2009; Zappaterra and Lehtinen, 2012; Vera et al., 2013).
Themain constituents of eCSF are proteins whose enrichment
is several folds higher during embryonic stages than in the adult
cerebrospinal fluid (Birge et al., 1974; Dziegielewska et al., 1980).
Proteomic analysis of eCSF revealed the presence of several
factors related to cell differentiation or proliferation, such as
bone morphogenetic proteins (Lehtinen et al., 2011; Segklia
et al., 2012), lipoproteins (Parada et al., 2008a), the fibroblast
growth factor (Martin et al., 2006), the insulin growth factor
(Salehi et al., 2009; Lehtinen et al., 2011), the nerve growth
factor (Mashayekhi et al., 2009), sonic hedgehog (Hh; Huang
et al., 2010b), Wingless family proteins (Lehtinen et al., 2011;
Johansson et al., 2013), SCO-spondin (Vio et al., 2008; Vera
et al., 2013), and retinoic acid (Alonso et al., 2011) and associated
molecules such as its precursor, all-trans-retinol, and its carrier,
the retinol binding protein (Parada et al., 2008b). The roles
for some of these molecules have been described in vitro using
explants of neuroepithelial cells (Parada et al., 2008a; Vera et al.,
2013), with findings that lipoproteins and SCO-spondin have
important functions in neurodifferentiation.
Lipoproteins are water-soluble macromolecular carriers that
facilitate the delivery of lipid cargo into target cells. Different
lipoproteins are present in chick eCSF, especially between
stages HH20 to HH27, when maximum neuronal differentiation
of neuroprogenitor cells occurs. At these stages, the main
lipoproteins are low-density lipoproteins (LDL) and very low
density lipoproteins (VLDL; Bachy et al., 2008; Parada et al.,
2008a). The presence of Apolipoprotein B (ApoB), the principal
proteic fraction of LDL, in the eCSF has been described in the
mouse and chicks, and its relevance during brain development
was revealed in ApoB-mutated or -knockout (KO) mice that died
at an early developmental stage and exhibited severely impaired
brain developments, such as exencephaly and hydrocephaly
(Homanics et al., 1993; Farese et al., 1995).
In vitro experiments have shown that LDL is critical
during early stages and promotes the neurodifferentiation and
proliferation of neuroepithelial cells. In fact, Parada et al.
(2008a) described that LDL is by itself capable of generating the
same neurodifferentiation inmesencephalic explants as complete
eCSF. However, adding LDL together with an eCSF fraction
depleted of lipoproteins to the culture medium decreased
neurodifferentiation by 60%. This result suggests that LDL is a
potent neurogenic factor regulated by proteins present in the
eCSF.
SCO-spondin is a glycoprotein of the thrombospondin family
with a high molecular weight (Gobron et al., 1996; Didier
et al., 2007). SCO-spondin is secreted by the diencephalic roof
plate from early stages of development, both basally, into the
extracellular matrix (ECM), where it comes into contact with
posterior commissure axons, and apically, into the eCSF, where it
can be found as a soluble or aggregated (forming Reissner’s fiber)
molecule (Schoebitz et al., 1986; Rodríguez et al., 1998; Caprile
et al., 2009; Stanic et al., 2010; Vera et al., 2013).
Regarding its functions, in vivo analysis using shRNA
to knockdown SCO-spondin in G. gallus embryos showed
increased neuroepithelium proliferation and decreased
differentiation, together with diencephalon and mesencephalon
hyperplasia and other morphological defects on the posterior
commissure and pineal gland. In vitro experiments confirmed
the importance of eCSF-derived SCO-spondin, where
mesencephalic explants cultured in the presence of eCSF
abruptly diminished neurodifferentiation but increased the
number of undifferentiated cells after the addition of SCO-
spondin antibodies. Together, these results indicate that
SCO-spondin is essential for embryonic development and that it
regulates the balance between neuroepithelial proliferation and
differentiation (Vera et al., 2013).
SCO-spondin is a giant protein with multidomain
organization that includes, among others, 26 thrombospondin
type 1 repeats (TSR; implicated in protein-protein interactions)
and eight contiguous LDL receptor class A domains (LDLrA;
Didier et al., 2007). Within the members of the LDL receptor
family, the LDLrA domain is also repeated in tandem and
comprizes the protein region responsible for LDL binding
proprieties (Russell et al., 1989; Yamamoto and Ryan, 2009).
The presence of both molecules in the eCSF, SCO-spondin with
LDLrA domains and LDL, allow us to suggest that SCO-spondin
could be binding LDL, and probably others molecules, thereby
controlling the effects of neurodifferentiation.
The present work provides evidence that LDL and SCO-
spondin from the eCSF form a complex, and that this interaction
is important in modulating the neuroepithelium differentiation
generated by both molecules.
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Material and Methods
Chick Embryos
Fertilized chick eggs were incubated at 38◦C in a humidified
incubator for specific time intervals. Embryos were staged
according to Hamburger and Hamilton (1992). Experiments
were conducted following the guidelines outlined in the
Biosafety and Bioethics Manual of the National Commission
of Scientific and Technological Research (CONICYT, Chilean
Government) and the Ethics Committee of the University of
Concepción.
eCSF Extraction
Embryonic cerebrospinal fluid from HH23 and HH30 embryos
was obtained as previously described (Gato et al., 2005) with
slight modifications. In order to avoid contamination with
neuroepithelial cells, eCSF was gently sucked up under the
dissecting microscope with a glass micro-needle that was
carefully introduced into the middle of the mesencephalic cavity.
To minimize protein degradation, eCSF samples were kept
at −15◦C with a protease inhibitor cocktail (Sigma P2714),
aliquoted, and frozen at−80◦C until use.
Organotypic Cultures of Mesencephalic
Neuroectoderm
Organotypic cultures of optic tectum were performed as
described by Gato et al. (2005) and maintained at 37◦C with
5% CO2 for 24 h in the presence of 0.01 mM 5-Bromo-
2′-deoxyuridine (BrdU; Sigma) and one of the six following
media: (i) Dulbecco’sModified Eagle’s medium (DMEM; Sigma);
(ii) Conditioned medium obtained from the supernatant of
HH36 subcommissural organ (SCO) culture maintained for
4 days in DMEM. The presence of SCO-spondin in this
medium was confirmed by Western blot (Vera et al., 2013);
(iii) Conditioned medium containing SCO-spondin plus anti-
SCO-spondin (1:300); (iv) 0.02 µg/µl of LDL in DMEM; (v)
0.02 µg/µl of LDL in conditioned medium containing SCO-
spondin; or (vi) the same as medium (v), but with the addition
of anti-SCO-spondin (1:300). After 24 h, the explants were fixed
in 4% paraformaldehyde for 20 min, dehydrated in ascending
concentrations of alcohols, and embedded in Paraplast. The
explants were oriented to obtain 5–7 µm thick frontal sections of
the mesencephalon explant. Sections were immunostained with
mouse monoclonal primary antibodies raised against anti-BrdU
(G3G4, Developmental Studies Hybridoma Bank, University of
Iowa, Iowa City, IA) and anti-βIII tubulin (clone Tuj1, Promega,
Madison, WI, USA) antibodies.
Antibodies were diluted in a Tris-HCl buffer containing
1% bovine serum albumin (Tris-BSA). Alexa Fluor 546 Goat
anti-mouse (Invitrogen, Carlsbad, CA, USA) was diluted to
1:100 in Tris-BSA and incubated for 2 h at room temperature.
Nuclei were visualized with TO-PRO-3 (Invitrogen, Carlsbad,
CA, USA). Images were acquired with a laser confocal Nikon
Eclipse TE2000-U microscope. The proliferation process was
measured by analyzing the quantity of BrdU positive nuclei vs.
the total explant area, while the process of neurodifferentiation
was measured by the area stained with tubulin βIII vs. the total
explant area. These analyses were performed with the ImageJ
program by measuring the area of the explant, followed by
transforming the image into binary and counting the number
of nuclei or the immunopositive area. Each condition was
repeated in triplicate, and statistical analyses were performed
using the Student’s t test, differences were considered significant
at p< 0.05.
Agarose Gel and Sudan Black Staining of Lipids
20 µl of eCSF from HH23 embryos were stained at 4◦C
overnight with 10 µl of 1% Sudan black previously diluted in
30% ethanol. Following this, the samples were loaded onto 0.8%
agarose gel with 0.05 M barbital buffer pH 8.6, thereby allowing
visualization of lipid components as black bands. Afterwards,
the gel was electrotransferred onto a nitrocellulose membrane
in a buffer containing 25 mM TRIS-HCl pH 8.3, 192 mM
glycine, 0.2% SDS, and 20% methanol, at 100 mA for 5 h.
Nonspecific protein binding sites were blocked by incubating
the nitrocellulose membranes with 5% nonfat milk in a 0.1
M phosphate saline buffer containing 0.1% Tween-20 for 2 h
at room temperature. The lipid bands maintained their black
color stain after transference, allowing for the identification of
the different lipoproteins. As lipoprotein controls, commercial
human LDL (Sigma L8292), human HDL (kindly donated by
C. Radojkovicby; González-Pecchi et al., 2015), and fetal bovine
serum were used.
Membranes were probed overnight with a rabbit anti-
Reissner’s fiber glycoproteins (AFRU) antibody (1:5000) that
recognizes SCO-spondin (Caprile et al., 2009), followed by
incubation with anti-IgG rabbit secondary antibody (1:5000;
Jackson Immunoresearch) for 2 h at room temperature. For
Western blots of the immunoprecipitates, SCO-spondin was
detected through the anti-rat SCO-spondin antibody and anti-
IgG rat secondary antibody (1:5000; Jackson Immunoresearch).
Immunoreactive proteins were detected with an enhanced
chemiluminescence system (SuperSignal, Pierce) according to
the manufacturer’s instructions.
Coimmunoprecipitation
Immunoprecipitation was performed using the Pierce Classic
IP Kit (Thermo Scientific, 26146) following the manufacturer’s
instructions. The column for immunoprecipitation was prepared
with 50 µl of protein A agarose, which was washed three times
with 100 µl wash buffer (0.025 M Tris, 0.15 M NaCl, 0.001 M
EDTA, 1% NP-40, 5% glycerol, pH 7.4) and centrifuged at 4◦C
and 1000 g for 1 min. The eCSF of HH23 embryos incubated
with anti-SCO-spondin (1:100) at 4◦C overnight was added to
the column and incubated at 4◦C for 3 h with agitation, followed
by centrifugation at 1000 g for 1 min. The column was then
washed three times with 200 µl of Tris buffer followed by
centrifugation at 1000 g for 1 min. Finally, elution was performed
with the elution buffer contained in the Pierce Classic IP Kit
followed by centrifugation at 1000 g for 1 min. This elution was
repeated five times. The eluates were stained with Sudan black
and loaded onto a 0.8% agarose gel with 0.05 M barbital buffer
pH 8.6 in order to analyze the presence of lipoproteins in the
immunoprecipitate.
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Immunohistochemistry
For colocalization of ApoB and SCO-spondin in the
mesencephalon, brain tissue of HH24 embryos was fixed in
4% paraformaldehyde for 12 h and processed following the same
protocols described for mesencephalic explants. The brain was
oriented in order to obtain sagittal sections. The antibodies
used were anti-ApoB (1:100; Bustos et al., 1998) and anti-SCO-
spondin (1:5000; Caprile et al., 2009), while vimentin (1:1; H5,
Developmental Studies Hybridoma Bank, University of Iowa,
Iowa City, IA) was used as a control.
Bioinformatics Analyses
Bioinformatics analyses were performed for the region of
SCO-spondin (Accession: NP_001006351.2; GI: 110082727) that
contains eight LDLrA domains arranged in tandem. This region
is located between amino acids 1363 and 1740 and contains 377
amino acids.
The primary structures of these domains were compared
to one another and with the LDLrA domains contained in
the human (Homo sapiens) LDL receptor sequence (Accession:
NP_000518.1; GI: 4504975) using the Clustal Omega program.
The hydrophobicity of this SCO-spondin fragment was
analyzed using the Kyte and Doolittle ProtParam algorithm
supplied by the ExPASy proteomic tool1 with an open window
of nine amino acids.
The Neff-PPAS algorithm predicted the tertiary structure,
and stereochemistry validation of the model was performed with
RAMPAGE2 and visualized with PyMol v.0.98.3 The obtained
structure model was validated by analyzing the phi (ϕ) and
psi (ψ) torsion angles and determined using a Ramachandran
plot.
Results
The possible interaction between SCO-spondin and LDL
was analyzed by three different experimental approaches: (1)
Bioinformatics analyses of the SCO-spondin region that contains
eight LDLrA domains in tandem and of comparisons with the
LDL receptor consensus sequence; (2) Analysis of the physical
interactions of both molecules through colocalization in native
agarose gels, using immunohistochemical colocalization in
embryonic chick brain, and through the coimmunoprecipitation
of LDL with SCO-spondin antibodies; and (3) Analysis of
functional interactions when these molecules were added to a
culture medium of mesencephalic explants.
Bioinformatics Analyses of SCO-Spondin
The SCO-spondin of G. gallus (Accession: NP_001006351.2; GI:
110082727) is a giant protein of 5225 amino acids that contains
several LDLrA domains. In order to perform bioinformatics
analyses, the region contained between amino acids 1363 and
1740 was selected because it contains a cluster of eight LDLrA
domains. The sequences of these domains were compared using
1http://www.expasy.org/tools/
2http://mordred.bioc.cam.ac.uk/∼rapper/rampage.php
3http://www.pymol.org
Clustal Omega with the seven LDLrA domains present in the
human LDL receptor (Figure 1A). The results showed a total
conservation of the six structurally important cysteines as well
as a high conservation of the DxSDE motif, which is important
for the Ca++ and LDL binding described in all the members
of the LDLr family (Daly et al., 1995; Jeon and Blacklow, 2005;
Guttman et al., 2010). In summary, the LDLrA domains present
in SCO-spondin contained the consensus sequence important to
maintaining domain stability and the ligand binding proprieties
of LDL receptor family members.
Previous studies on the LDL binding capacities of human
LDLr demonstrated that a cluster of LDL motifs is necessary,
but only the central LDLrA motifs are crucial for LDL binding
(Fisher et al., 2004). In this regard, SCO-spondin LDLrA4
maintained the DxSDE consensus sequence, and in LDLrA5
there was a conserved serine to threonine substitution, an
amino acid with equivalent features. Several LDL motifs were
conserved in all of the reported SCO-spondin sequences, but
there are no reports about the conservation of the amino
acids important for LDL binding. For this reason the LDLrA5
domains ofH. sapiens (Accession: NP_940857.2; GI: 134031945),
Bos taurus (Accession: NP_777131.1; GI: 28195400), Mus
musculus (Accession: CAD42654.1; GI: 27527438), and Rattus
novergicus (Accession: NP_001007017.1; GI: 55741770) were
analyzed. The results showed that all of these conserved the six
cysteines and the DxS/TDE motif important for LDL binding
(Figure 1B).
The hydropathic characteristics of the SCO-spondin fragment
containing the LDL domains were plotted using the ExPASy
Protscale tool. The hydropathic index of the entire fragment
was −0.406 Kj/mol. This suggests that, due to its hydrophilic
character, this fragment would be on the SCO-spondin surface
and exposed to eCSF. A detailed analysis of the Kyte and
Doolittle Hydropathy Plot revealed that the most hydrophilic
peaks corresponded to DxSDE motifs (Figure 1C).
The tertiary structure of the SCO-spondin fragment was
predicted with the Neff-PPAS program, available in the LOMETS
server, using 1n7d (extracellular region of human LDLr) as
a template. The model was visualized using PyMol v.0.98
(Figure 1D).
Validation of the obtained structural model was performed
by inspecting the backbone conformation through analyzing the
phi (ϕ) and psi (ψ) torsion angles. The predicted conformation
was a stable structure with 278 amino acids in favored positions
(75.9%), 64 amino acids in allowed positions (17.3%), and 25
amino acids in atypical positions (6.8%).
An important feature of the predicted tertiary structure was
that the LDLrA domains surrounded a central pocket that in
other members of the LDL receptor family has been proposed
as the region occupied by the LDL molecule (Huang et al.,
2010a). Considering this, the tertiary structure prediction of
this study showed that DxSDE motifs (Figure 1D, in green)
were exposed to this central pocket, especially in the central
LDLrA3, 4, 5, and 7 domains. As stated before, in other
members of the LDL receptor family, these central LDLrA
domains are the most relevant for LDL binding (Fisher et al.,
2004).
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FIGURE 1 | Bioinformatics analyses of LDLrA domains present in the
SCO-spondin sequence of Gallus gallus. (A) Multiple alignment of
SCO-spondin LDLrA domains and comparison with the LDLrA domain
sequence of the human LDL receptor (LDLRh). (B) Multiple alignment of the
SCO-spondin LDLrA5 domain from different species. For all species analyzed
this domain conserved the DxSDE motif, or a conservative substitution of serine
to threonine (in red). (C) Hydropathic plot of the SCO-spondin sequence that
contains the LDLrA domains, showing its hydrophilic character, especially for
the regions containing the DxSDE motifs. (D) Tertiary structure of the
SCO-spondin region that contains the LDLrA domains arranged in tandem.
Each domain is shown in a different color; DxSDE motifs are highlighted in
green, and disulfide bridges are in white.
Physical Interaction Between LDL
and SCO-Spondin
In order to study the LDL/SCO-spondin interaction, a protocol
for lipoprotein detection was previously standardized based on
Parada et al. (2008a). Thus, eCSF was incubated with Sudan
black, a lipophilic stain, which was followed by native agarose
gel electrophoresis. As controls, commercial human LDL, HDL
purified from human serum (González-Pecchi et al., 2015),
and fetal bovine serum were used. The results showed that
at early stages of development, the eCSF of chick embryos
contained different lipoproteins, with LDL being the most
evident (Figure 2A). As expected, the LDL and HDL of the eCSF
did not have a migration pattern identical to human LDL and
HDL, since these lipoproteins have different sizes depending on
age and gender (McNamara et al., 1987).
As a first approximation to study the possible interaction
between LDL and SCO-spondin, a migration analysis of both
molecules was performed in native agarose gels. For this, eCSF
from HH30 chick embryos was incubated with Sudan black,
followed by native agarose gel electrophoresis (Figure 2B) and
electrotransference to a nitrocellulose membrane controlled by
nitrocellulose black staining (Figure 2C). The membrane was
then incubated with anti-SCO-spondin for Western blot analysis
(Figure 2D). In order to better separate the different components
of the eCSF, the running time of electrophoresis was increased,
although this generated some spreading of lipoproteins in the gel
(compare Figures 2A,B). The results showed that LDL and SCO-
spondin from chick eCSF had an identical migration pattern in
native agarose gels, suggesting a possible interaction between
these molecules.
The physical interaction between SCO-spondin and LDL was
analyzed by coimmunoprecipitation assays. For this, the eCSF
from HH23 embryos was previously incubated for 4 h with 0.001
µg/µl of commercial LDL followed by immunoprecipitation
with anti-SCO-spondin antibodies. The immunoprecipitate, as
well as the last wash, were stained with Sudan black, followed
by agarose gel electrophoresis, which showed that LDL was
present in the immuprecipitate (Figure 3A). The gel was then
electrotransferred in order to check if SCO-spondin was also in
the immunoprecipitate. The presence of this protein was found
in the same elution aliquots as LDL (Figure 3B). This result
suggest that both proteins form a complex in the eCSF. Note that
after the elution (pH 2.8) the molecular interactions are broken,
including the LDL/SCO-spondin complex, and the isoforms of
SCO-spondin migrated differently than in the Figure 2D.
The formation of this LDL/SCO-spondin complex was
also studied by double immunohistochemistry using anti-
SCO-spondin and anti-ApoB (the main proteic fraction of
Frontiers in Neuroanatomy | www.frontiersin.org 5 May 2015 | Volume 9 | Article 72
Vera et al. eCSF-derived LDL and SCO-spondin interaction
FIGURE 2 | Migration pattern of lipoproteins and SCO-spondin
from the eCSF. (A) Detection of eCSF lipoproteins by staining with
Sudan black and posterior native agarose gel electrophoresis, showing
the presence of low density lipoproteins (LDL) and high density
lipoproteins (HDL) (arrows) in the eCSF of HH30 chick embryo. Human
LDL and HDL and fetal bovine serum (FBS) were used as positive
controls. (B–D) Migration pattern of lipoproteins and SCO-spondin
present in the eCSF. (B) Native agarose gel electrophoresis stained with
Sudan black (lipid stain), revealing the presence of lipoproteins (arrows) in
the eCSF and fetal bovine serum (FBS; control). (C) Transference of the
gel shown in (B) to nitrocellulose membrane. (D) Western blot with
anti-SCO-spondin of the nitrocellulose membrane shown in (C), revealing
a migration pattern of SCO-spondin identical to the eCSF LDL stained
with Sudan black (B,C).
FIGURE 3 | Coimmunoprecipitation of LDL and SCO-spondin from the
eCSF. (A) Native agarose gel electrophoresis of eCSF from HH23 chick
embryo immunoprecipitated with SCO-spondin antibodies. Lane 1: LDL
commercial. Lane 2: W5: last wash of the immunoprecipitate, revealing the
absence of lipoproteins. Lane 3–5: Elution fractions of the immunoprecipitate,
showing the presence of LDL. (B) Western blot with anti-SCO-spondin of the
gel shown in (A), revealing the presence of this protein in the eluted fractions.
LDL) antibodies. Immunohistochemical analysis of HH24 chick
brain revealed immunoreactivity for both antibodies on the
apical region of neuroepithelial mesencephalic cells (arrows in
Figures 4A–D), as well as in eCSF particles present in the
encephalic cavities (arrowheads in Figures 4A–D). As a negative
control, the location of vimentin, an intermediate filament, was
analyzed, finding that it was not present in either eCSF particles
or in the apical region of the neuroepithelial cells (Figures 4E–G).
Functional Interaction Between LDL and
SCO-Spondin
The capacity of LDL and SCO-spondin to increase
neurodifferentiation in embryonic mesencephalic explants when
separately added to the culture medium was previously reported
(Parada et al., 2008a; Vera et al., 2013). To elucidate the effect
that the LDL/SCO-spondin complex contained in the eCSF could
have on neuroepithelial tissue development, mesencephalon
explants from HH20 chick embryos were cultured in the
presence of different media (Figure 5): (i) DMEM as a negative
control; (ii) Conditioned medium of SCO-explants containing
SCO-spondin (conditioned medium with SCO-spondin);
(iii) Conditioned medium with SCO-spondin plus antibodies
against SCO-spondin; (iv) LDL; (v) Conditioned medium with
SCO-spondin plus LDL; and (vi) Conditioned medium with
SCO-spondin, LDL and anti-SCO-spondin. Cell proliferation
and neuronal differentiation were studied using anti-BrdU
and anti-βIII tubulin labeling, respectively. Proliferation and
neurodifferentiation were measured by accounting for BrdU
immunopositive nuclei and the area immunopositive for tubulin
βIII, respectively, in relation to the total area of the explant
using the ImageJ program. For this, the total area of the explant
was delimited and measured (Figure 6A); the immunopositive
area was transformed to binary (Figure 6C), and the number of
nuclei or the total area was analyzed by the ‘‘Analyze particles’’
option (Figure 6D).
Neurodifferentiation (Figure 6E). As reported before, SCO-
spondin (Figure 5B) and LDL (Figure 5G) were able to
increase the number of positive tubulin βIII cells several times
as compared to explants maintained in DMEM (Figure 5A).
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FIGURE 4 | Inmunohistochemical localization of ApoB and
SCO-spondin. (A) Sagittal sections of dorsal mesencephalon of HH24
chicken embryos. Immunohistochemistry with antibodies against
SCO-spondin (green) and ApoB (red) counterstained for nuclei with
TO-PRO-3 (blue). (B–D) Higher magnification of (A), showing strong
immunoreactivity for SCO-spondin (C) and ApoB (D) in the apical region
of neuroepithelial cells (arrows). Arrowheads show particles in the
encephalic cavities positive for both antibodies. (E–G)
Immunohistochemistry with anti-vimentin (red) as a negative control.
Scale of bars is 50 µm in (A, E–G); 10 µm in (B–D).
On the other hand, the addition of anti-SCO-spondin in the
culture medium almost completely inhibited the neurogenic
capacity of SCO-spondin (Figure 5C). The most relevant result
of this experiment was that the addition of LDL and SCO-
spondin at the same time diminished the neurogenic effect
that both molecules had separately (Figure 5H). This result
suggests that LDL and SCO-spondin interact, and that this
interaction inhibits their neurogenic effect. This possibility
was reinforced by the observation that the incorporation of
SCO-spondin antibodies did not have any effect (Figure 5I),
reflecting that SCO-spondin is already inhibited when it forms
part of the complex. In the same context, the remnant
neurodifferentiation observed in presence of LDL/SCO-spondin
(with or without anti-SCO-spondin) might be a consequence
of free LDL molecules that do not form part of the complex
(Figures 6K,L).
Cellular proliferation (Figure 6F). As in previous reports
(Vera et al., 2013), SCO-spondin did not generate a significant
difference in cellular proliferation as compared to a DMEM
control (Figures 5D,E). However, the addition of LDL to
the culture medium generated a twofold increase in this
parameter (Figure 5J). When both molecules were added
together, proliferation was similar to explants maintained in
LDL alone (Figure 5H) suggesting that the free LDL molecules
were sufficient to exert a proliferative effect. This possibility
was sustained by the observation that the addition of anti-
SCO-spondin antibodies did not have any effect as compared
to explants maintained in LDL alone or in LDL/SCO-spondin
(Figures 5J–L, 6F).
Discussion
Embryonic cerebrospinal fluid is an active signaling center
that regulates neuroepithelium development. It contains several
morphogens, however, there are no reports about the possible
interactions between the different eCSF molecules or how
these interactions would modulate their morphogenic roles. The
present work showed the interaction between SCO-spondin and
LDL, two potent neurogenic molecules present in the eCSF, and
how this interaction modulates their neurogenic capacities.
Bioinformatics Analyses of SCO-Spondin
All members of the LDL receptor family present a cluster of
LDLrA domains repeated several times, a condition that is
necessary and sufficient to bind LDL (Russell et al., 1989). This
domain has a length of 35–40 amino acids and is characterized
by the presence of six cysteines responsible for conformation
and a DxSDE motif responsible for ligand binding. In this study,
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FIGURE 5 | Immunohistochemistry of mesencephalic neuroepithelial
explants under various experimental conditions. Optic tectum explants
from HH20 embryos cultured for 24 h in the presence of: (i) DMEM as a
negative control (A,D); (ii) Conditioned medium from SCO culture explants
(B,E); (iii) Conditioned medium from SCO culture explants plus
anti-SCO-spondin antibodies (C,F); (iv) DMEM in the presence of LDL (G,J);
(v) Conditioned medium from SCO culture explants in the presence of LDL
(H,K); and (vi) The same as (v), but with anti-SCO-Spondin (I,L). The explants
were analyzed for the presence of βIII tubulin (A–C, G–I) and BrdU incorporation
(D–F, J–L). Panels (A′–L′) show the merger, with the TO-PRO-3 nuclear signal
used to counterstain the tissue in red. Scale bar in A is 50 µm, all the images
have the same magnification.
a detailed analysis of the LDLrA domains present in SCO-
spondin revealed that this protein contained all of the features
necessary to bind LDL, since it had a cluster of eight LDLrA
domains, each one with six cysteines, and a highly conserved
ligand binding motif (Figure 1A). Moreover, these structures
were conserved not only between the different LDLrAs of chick
SCO-spondin, but also in the SCO-spondin of the different
species analyzed (Figure 1B). Conformational analysis of the
SCO-spondin fragment containing the LDLrA domains revealed
similarity with the structure reported for human LDLr (Rudenko
and Deisenhofer, 2003), with these domains surrounding a
central pocket to which DxSDE negative motifs are exposed.
Structural analysis in human LDLr revealed that this pocket
is occupied by the ligand that contains positively charged
amino acids on the surface (Hussain et al., 1999; Rudenko and
Deisenhofer, 2003; Huang et al., 2010a).
Protein searches in the ExPASy PROSITE protein domain
database revealed relatively few proteins containing this domain,
and those found were principally proteins of the complement
system or members of the LDL receptor family. Surprisingly,
besides SCO-spondin, there is only one secreted protein that
contains a cluster of this domain; a Drosophila mosaic protein
called Nudel that has been reported crucial for early development
since its inhibition generates the dorsalization of Drosophila
embryos (Hong and Hashimoto, 1995; LeMosy et al., 2000).
However, the LDL binding capacity of Nudel has not been
studied, and there is no information on the functions of the
eleven LDLrA domains that it contains.
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FIGURE 6 | Quantitative analysis of proliferation and neurodifferentiation
in mesencephalic explants under various experimental conditions. (A–D)
Steps performed to quantify cell proliferation and differentiation using the
ImageJ program. (A) The explants were enclosed and the total area measured
(box in A). (B–C) The image of the immunostained explant (without TOPRO-3)
was transformed to a binary image. (D) The total number of particles from the
binary image were measured (count in box D), and the area occupied by these
particles was summarized (total area in box D). When the analyzed figure was
immunostained with anti-BrdU, the count represented the number of positive
nuclei. When the analyzed figure was immunostained with anti-tubulin βIII, the
total area represented the magnitude of neurodifferentiation. (E) Quantitative
analysis of neuroepithelial cells undergoing neural differentiation, as measured
by the % of area positive for tubulin βIII. (F) Quantitative analysis of cell
proliferation was measured by the number of BrdU-positive cells per area.
(G–M) Scheme showing the interpretation of proliferation and
neurodifferentiation analyses. The results showed that SCO-spondin by itself
was able to promote the neurodifferentiation of neuroepithelial cells (E,H), but
this capacity drastically diminished in presence of anti-SCO-spondin (E,I) or
LDL (E,K). On the other hand, LDL by itself was able to promote
neurodifferentiation (E,J) and proliferation (F,J). The proliferation generated by
LDL was independent of the presence of SCO-spondin and anti-SCO-spondin,
but, rather, neurodifferentiation decayed in the presence of SCO-spondin (with
or without anti-SCO-spondin), suggesting that the LDL-SCO-spondin complex
is unable to promote neurodifferentiation. Statistical analyses were performed
using the Student’s t test, *p < 0.05; **p < 0.01. Bars represent the mean ±
SEM of three experiments.
In summary the bioinformatics analyses revealed that SCO-
spondin, at least in theory, possesses the elements necessary to be
a LDL binding protein.
Physical Interaction Between LDL
and SCO-Spondin
A physical interaction between the SCO-spondin and LDL
present in the eCSF was suggested by the identical migration
pattern of both molecules in native agarose gel (Figure 2), a
possibility reinforced by the immunoprecipitation of LDL with
SCO-spondin antibodies (Figure 3). To our knowledge, this is
the first report showing the binding of LDL to a soluble carrier
molecule.
Immunohistochemical analysis of ApoB and SCO-spondin
in the embryonic mesencephalon revealed that both molecules
colocalize in the apical membrane of neuroepithelial cells and in
eCSF particles (Figure 4). The presence of particles containing
lipoproteins was previously reported (Bachy et al., 2008). These
authors described the presence of lipoproteins positive for
ApoA1 in the eCSF of four-day-old chick embryos, and although
ApoA1 mRNA cannot be detected in the brain, the authors
found immunoreactivity in the apical region of neuroepithelial
cells. These results suggest that extrinsic lipoproteins travel in
the eCSF, probably as particles, and enter neuroepithelial cells
through the apical membrane in contact with the eCSF. The
present immunohistochemical data support this idea and shows
that eCSF particles contain SCO-spondin.
Functional Interaction Between LDL
and SCO-Spondin
The functional interaction between SCO-spondin and LDL
binding was studied by adding these molecules to the
culture medium of mesencephalic explants. In these assays,
the formation of LDL/SCO-spondin complex diminished the
neurogenic effect of both molecules, but not their proliferative
influence (Figures 5, 6E,F). This result is highly relevant
since both molecules have a potent effect on neuroepithelial
development, and there are currently no reports about regulatory
mechanisms.
As was expected, the presence of SCO-spondin or LDL
increased neurogenesis in mesencephalic explants. However,
an unexpected result was obtained when both molecules were
included simultaneously, with neurogenic activity decreasing
below the activity found for each molecule separately. This result
opens the possibility that SCO-spondin may be binding and
transporting LDL when this molecule is highly concentrated
and releasing it back to the eCSF when and/or where LDL
concentration is low. A similar ‘‘buffering’’ or sequestering
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function for SCO-spondin was described in vivo at the adult stage
(Caprile et al., 2003), showing that SCO–spondin participates
in the regulation of monoamines CSF concentration. This
regulation may occur either by binding and transporting
monoamines away or by transiently binding and releasing them
back to the CSF, thereby maintaining a constant monoamines
concentration (Caprile et al., 2003). In this case, the binding
capacity of SCO-spondin monoamines seems to require the
TSR domain, since it has sequence similarity with different
monoamine transporters (Rodríguez and Caprile, 2001).
The possible function of SCO-spondin as an LDL carrier
becomes more relevance when taking into account that the
majority of eCSF molecules, LDL included, originate in the
plasma (Gato et al., 2004; Parvas et al., 2008). At early stages
of development, the transfer of plasma molecules to the eCSF
takes place through specific perineural blood vessels located in
the ventral mesencephalon and the most anterior part of the
ventral prosencephalon, lateral to the floor plate (Parvas et al.,
2008). The flow of plasma LDL to the eCSF at this location
should generate high local LDL concentration. In this region the
brain cavities narrow (future Sylvian aqueduct), and the caudal
diencephalic roof plate (where SCO-spondin is secreted) faces
the point of entry for plasma molecules, an element that would
facilitate binding to SCO-spondin.
For future investigations, it will be interesting to perform
similar in vitro experiments with different concentrations of
LDL and SCO-spondin in order to study affinity in comparison
with other members of the LDL receptor family, in addition
to researching the capacity of SCO-spondin to bind and
release LDL.
SCO-Spondin, a Carrier of Morphogens
in the eCSF?
The binding of SCO-spondin to LDL showed in the present
work opens new questions about possible role of SCO-spondin
as a morphogen carrier. This possibility is supported by different
aspects. Firstly, LDL can carry morphogens of the Hh and
Wnt families (Panáková et al., 2005; Willnow et al., 2007). The
association between SCO-spondin and lipoprotein-morphogens
might have several advantages, such as morphogen mobilization
around brain cavities or allowing for the presence of multiple
copies of Wnt or Hh on the same lipoprotein particle. These
multiple copies would in turn generate a multivalent ligand
complex that might be able to promote a homomeric clustering
of their respective cognate receptors, as well as heterodimeric
interactions between different morphogens (Willnow et al.,
2007).
Secondly, LDLrA domains are characterized by the high
number of ligands they can bind (Hussain et al., 1999; Strickland
et al., 2002). The high versatility of this protein family resides
in the flexibility reported for the linker region between the
different LDLrA domains that allow them to adapt to different
ligands. Likewise, binding occurs not only to a wide range
of apolipoproteins present in different lipoproteins, but also
to extracellular glycoproteins, such as thrombospondin-1, F-
spondin or reelin (Divekar et al., 2014). In this regard, the present
investigation did not study the binding of SCO-spondin to other
ligands, but this is a possibility that should be explored.
Finally, SCO-spondin is a giant protein of more than
5000 aminoacids, with a modular structure composed by the
LDLrA domains described, 26 TSR domains, and one EGF-
like domain, among others. The presence of other domains
in SCO-spondin, such as the TSR domains that interact with
integrins (Caprile et al., 2009) and bind and activate TGF-β
(Yee et al., 2004; Young and Murphy-Ullrich, 2004), increase
the level of possible interactions and the complexity of this
protein’s function. For future investigations on the role of
SCO-spondin in the differentiation of neuroepithelial cells,
it would be interesting to characterize the different isoforms
of SCO-spondin present in this fluid and the interaction of
these isoforms not only with LDL but also with other eCSF
molecules.
Taken together, these data prompt us to conclude that
eCSF is not the sum of molecules with independent effects. In
contrast, as it occurs within the ECM, it facilitates the interaction
between different molecules and may serve as a reservoir for and
distributor of different morphogens.
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